Neurotech International Ltd
ASX:NTI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Neurotech International Ltd
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
| Market Cap | P/B | ||||
|---|---|---|---|---|---|
| AU |
|
Neurotech International Ltd
ASX:NTI
|
64.1m AUD | 13.4 | |
| US |
|
Shockwave Medical Inc
NASDAQ:SWAV
|
215.1B USD | 286.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.6B USD | 4.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
151.8B USD | 10.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
131.9B USD | 6.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.8B USD | 5.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.8B USD | 2.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 2.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
61.5B EUR | 3.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.8B USD | 7.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
360.4B CNY | 10.9 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
You don't have any saved screeners yet
